Director of Translational Biology and Pharmacology, Priya Handa, PhD, and Senior Director of Discovery and Platform, Thach Mai, showcased our research at the 23rd Biopharma Drug Discovery Nexus Conference in San Francisco
CEO Dr. Hanadie Yousef shares insights on a panel, “Entrepreneurial Excellence in BioPharma: Lessons from the Frontlines,” at SynBioBeta – The Global Synthetic Biology Conference in San Jose
CEO Dr. Hanadie Yousef shares an Industry Update on JUV-161 and our plans to initiate Phase 1 studies this year at the 2025 International MDF Conference in Indianapolis
Our CEO, Hanadie Yousef, discussed Juvena’s growing and advancing pipeline of tissue restorative biologics for myopathies and obesity with Miranda Schmalfuhs from Pharmaceutical Executive
Our Senior Director of Discovery and Platform, Dr. Thach Mai, attended Google Cloud Next ‘25 to explore cutting-edge AI and cloud innovations transforming drug discovery and precision therapeutics
Dr. Hanadie Yousef gave a talk on “Building a Pipeline with Purpose: Turning a Platform into Strategic Asset Value” as an invited speaker at Fierce Pharma Engage BD&L Summit in San Diego
Juvena was honored to present at the IGF and Insulin System in Physiology and Disease Gordon Research Conference! Our CSO and Co-Founder, Jeremy O’Connell, had a great opportunity to present our JUV-161 program and engage in insightful discussions on the latest advancements in IGF biology
